Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexamethasone and Blood Sugar in Diabetic Foot Surgery
NCT03871049Completed
- Sponsor
- Assiut University
- Start
- Jan 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in diabetic foot disease (DFD) (2 arms), sponsored by Assiut University. Primary endpoint: Blood sugar level at 24 hours. Started Jan 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic foot disease (DFD)
Beyond the preview
Go deeper on NCT03871049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03871049.